Stockscreener 앱 받기
5.97
4.63%
-0.29
시간 외 거래:
5.85
-0.12
-2.01%
전일 마감가:
$6.26
열려 있는:
$6.2
하루 거래량:
608.63K
Relative Volume:
1.11
시가총액:
$457.78M
수익:
$1,000.00K
순이익/손실:
$-48.81M
주가수익비율:
-7.7162
EPS:
-0.7737
순현금흐름:
$-39.95M
1주 성능:
-14.96%
1개월 성능:
-20.72%
6개월 성능:
+197.01%
1년 성능:
+442.73%
1일 변동 폭
$5.80
$6.41
1주일 범위
$5.80
$7.115
52주 변동 폭
$0.712
$8.33
셰턱랩스 Stock (STTK) Company Profile
명칭
Shattuck Labs Inc
전화
512-900-4690
주소
500 W. 5TH STREET, AUSTIN
Compare STTK vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
5.97 | 480.02M | 1,000.00K | -48.81M | -39.95M | -0.7737 |
VRTX
Vertex Pharmaceuticals Inc
|
436.58 | 110.90B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
629.68 | 73.20B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
776.26 | 49.71B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
286.27 | 38.32B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
144.37 | 30.97B | 742.00K | -1.37B | -1.07B | -7.0731 |
셰턱랩스 Stock (STTK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2026-03-06 | 재개 | Needham | Buy |
| 2026-01-28 | 개시 | Piper Sandler | Overweight |
| 2025-12-01 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-09-08 | 개시 | Wedbush | Outperform |
| 2025-03-17 | 개시 | Leerink Partners | Outperform |
| 2024-10-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-10-02 | 다운그레이드 | Needham | Buy → Hold |
| 2024-10-01 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-06-17 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-08-31 | 개시 | BTIG Research | Buy |
| 2022-06-01 | 개시 | Citigroup | Buy |
| 2022-05-02 | 개시 | H.C. Wainwright | Buy |
| 2021-04-14 | 개시 | Berenberg | Buy |
| 2021-01-11 | 개시 | Evercore ISI | Outperform |
| 2020-11-03 | 개시 | Citigroup | Buy |
| 2020-11-03 | 개시 | Cowen | Outperform |
| 2020-11-03 | 개시 | Needham | Buy |
모두보기
셰턱랩스 주식(STTK)의 최신 뉴스
Officer at Shattuck Labs (NASDAQ: STTK) exercises warrants for 12,805 shares - Stock Titan
Shattuck Labs (STTK) Stock Analysis: -6.15% Loss — Key Levels 2026-05-15Trending Volume Leaders - newser.com
Shattuck Labs (STTK) Declines -6.15% Amid Market Weakness 2026-05-15Trading Community - newser.com
Shattuck Labs (STTK) Delivers Q1 2026 Beat — EPS $-0.13 vs $-0.14 ExpectedSpecial Dividend - newser.com
T. Rowe Price holds 9.87M shares of Shattuck Labs (NASDAQ: STTK) amendment - Stock Titan
Insider Sell: Arundathy Pandite Sells 30,000 Shares of Shattuck Labs Inc (STTK) - GuruFocus
Shattuck Labs CMO Pandite sells $198,300 in stock By Investing.com - Investing.com Australia
Shattuck Labs CTO Abhinav Shukla sells $14,244 in shares - Investing.com UK
Shattuck Labs CMO Pandite sells $198,300 in stock - Investing.com
Shattuck Labs CTO Abhinav Shukla sells $14,244 in shares By Investing.com - Investing.com Australia
[Form 4] Shattuck Labs, Inc. Insider Trading Activity - Stock Titan
Shattuck Labs (STTK) CMO sells 30K shares under 10b5-1 plan - Stock Titan
Shattuck Labs stock (US8124231002): Down 5.29% in May 2026 amid biotech volatility - AD HOC NEWS
Shattuck Labs (STTK) CEO exercises warrants to acquire 25,610 common shares - Stock Titan
Shattuck Labs (NASDAQ: STTK) executive reports 968-share tax withholding - Stock Titan
[144] Shattuck Labs, Inc. SEC Filing - Stock Titan
We're Not Very Worried About Shattuck Labs' (NASDAQ:STTK) Cash Burn Rate - Yahoo Finance
STTK Maintained by Wedbush -- Price Target Raised to $11.00 - GuruFocus
Shattuck Labs Price Target Raised to $11.00/Share From $8.00 by Wedbush - Moomoo
Wedbush Raises Price Target on Shattuck Labs to $11 From $8, Keeps Outperform Rating - Moomoo
SL-325 Data Catalysts and Phase 2 Launch Plans Underpin Buy Rating on Shattuck Labs - TipRanks
Shattuck Labs | 8-K: Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights - Moomoo
Shattuck Labs Releases Q1 2026 Financial Results - AlphaStreet
Shattuck Labs (NASDAQ: STTK) posts higher Q1 2026 loss but strengthens cash - Stock Titan
Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights - Investing News Network
Shattuck Labs (NASDAQ: STTK) posts Q1 2026 loss as DR3 program advances - Stock Titan
Shattuck Labs 1Q Rev $0.00 >STTK - Moomoo
Shattuck Labs, Inc. Completes Enrollment in Phase 1 Clinical Trial of SL-325, with Phase 2 Trial Planned for 2026 - Quiver Quantitative
Shattuck’s Crohn’s drug candidate clears enrollment, with Q2 data due - Stock Titan
BRIEF-Shattuck Labs Q1 Net Income USD -14.767 Million - TradingView
Shattuck Labs 1Q Loss/Shr 13c >STTK - Moomoo
Shattuck Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Shattuck Labs Stock Surges Following Positive Analyst Coverage - HarianBasis.co
Cantor Fitzgerald Initiates Coverage of Shattuck Labs (STTK) - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL) and Shattuck Labs (STTK) - The Globe and Mail
Shattuck Labs (STTK) to Release Earnings on Thursday - MarketBeat
5 Best Performing Small Cap Stocks So Far in 2026 - Insider Monkey
Cantor Fitzgerald initiates coverage of Shattuck Labs (STTK) with overweight recommendation - MSN
Shattuck Labs (STTK) price target increased by 24.00% to 12.65 - MSN
Shattuck Labs, Inc. (NASDAQ:STTK) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Piper Sandler initiated coverage on Shattuck Labs with a new price target - Quantisnow
STTK Initiated Coverage by Cantor Fitzgerald -- Rating Set to Ov - GuruFocus
STTK Initiated Coverage by Cantor Fitzgerald -- Rating Set to Overweight - GuruFocus
Shattuck Labs (STTK) Volatility Analysis | Shattuck Labs posts 13.9% EPS beat on smaller lossGuidance Upgrade - newser.com
HC Wainwright Forecasts Stronger Earnings for Shattuck Labs - MarketBeat
Shattuck Labs (NASDAQ:STTK) Hits New 1-Year HighTime to Buy? - MarketBeat
STTK Shattuck Labs posts narrower Q4 2025 loss than forecasts, shares climb 4.65 percent on positive investor sentiment.Sector Outperform - newser.com
H.C. Wainwright Maintains Shattuck Labs(STTK.US) With Buy Rating, Raises Target Price to $18 - Moomoo
Shattuck Labs (NASDAQ:STTK) Stock Price Up 6%What's Next? - MarketBeat
STTK Maintained by HC Wainwright & Co. -- Price Target Raised to $18 - GuruFocus
Shattuck Labs (STTK) Stock High Frequency (Skyrockets) 2026-04-20Stock Idea Sharing Hub - Cổng thông tin điện tử tỉnh Lào Cai
셰턱랩스 (STTK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.53%
자본화:
|
볼륨(24시간):